These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28915235)

  • 1. Transamniotic stem cell therapy: a novel strategy for the prenatal management of congenital anomalies.
    Fauza DO
    Pediatr Res; 2018 Jan; 83(1-2):241-248. PubMed ID: 28915235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transamniotic Stem Cell Therapy.
    Lazow SP; Fauza DO
    Adv Exp Med Biol; 2020; 1237():61-74. PubMed ID: 31302870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transamniotic stem cell therapy (TRASCET) in a rabbit model of spina bifida.
    Shieh HF; Tracy SA; Hong CR; Chalphin AV; Ahmed A; Rohrer L; Zurakowski D; Fauza DO
    J Pediatr Surg; 2019 Feb; 54(2):293-296. PubMed ID: 30518492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor mesenchymal stem cell linetics after transamniotic stem cell therapy (TRASCET) for experimental spina bifida.
    Shieh HF; Ahmed A; Rohrer L; Zurakowski D; Fauza DO
    J Pediatr Surg; 2018 Jun; 53(6):1134-1136. PubMed ID: 29580785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regenerative medicine and spina bifida: Recent developments in induced fetal regeneration.
    Fauza DO
    J Pediatr Rehabil Med; 2017 Dec; 10(3-4):185-188. PubMed ID: 29125510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida.
    Feng C; D Graham C; Connors JP; Brazzo J; Zurakowski D; Fauza DO
    J Pediatr Surg; 2016 Jun; 51(6):1010-3. PubMed ID: 27013425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells.
    Dionigi B; Ahmed A; Brazzo J; Connors JP; Zurakowski D; Fauza DO
    J Pediatr Surg; 2015 Jan; 50(1):69-73. PubMed ID: 25598096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transamniotic stem cell therapy (TRASCET) mitigates bowel damage in a model of gastroschisis.
    Feng C; Graham CD; Connors JP; Brazzo J; Pan AH; Hamilton JR; Zurakowski D; Fauza DO
    J Pediatr Surg; 2016 Jan; 51(1):56-61. PubMed ID: 26548631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-amniotic delivery of amniotic-derived neural stem cells in a syngeneic model of spina bifida.
    Turner CG; Pennington EC; Gray FL; Ahmed A; Teng YD; Fauza DO
    Fetal Diagn Ther; 2013; 34(1):38-43. PubMed ID: 23635813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida.
    Dionigi B; Brazzo JA; Ahmed A; Feng C; Wu Y; Zurakowski D; Fauza DO
    J Pediatr Surg; 2015 Jun; 50(6):1037-41. PubMed ID: 25929798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor mesenchymal stem cells home to maternal wounds after transamniotic stem cell therapy (TRASCET) in a rodent model.
    Graham CD; Shieh HF; Brazzo JA; Zurakowski D; Fauza DO
    J Pediatr Surg; 2017 Jun; 52(6):1006-1009. PubMed ID: 28363468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between placental and amniotic mesenchymal stem cells in transamniotic stem cell therapy for experimental gastroschisis.
    Chalphin AV; Tracy SA; Lazow SP; Kycia I; Zurakowski D; Fauza DO
    J Pediatr Surg; 2020 Jan; 55(1):49-53. PubMed ID: 31711742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniotic Fluid Stem Cells for the Treatment of Surgical Disorders in the Fetus and Neonate.
    Kunisaki SM
    Stem Cells Transl Med; 2018 Nov; 7(11):767-773. PubMed ID: 30085416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Mechanistic Screening of Transamniotic Stem Cell Therapy in the Rodent Model of Spina Bifida: Host Bone Marrow and Paracrine Activity.
    Lazow SP; Tracy SA; Chalphin AV; Kycia I; Zurakowski D; Fauza DO
    Fetal Diagn Ther; 2020; 47(12):902-911. PubMed ID: 32877907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene.
    Lazow SP; Labuz DF; Kycia I; Zurakowski D; Fauza DO
    J Pediatr Surg; 2021 Jun; 56(6):1226-1232. PubMed ID: 33771369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transamniotic stem cell therapy (TRASCET) in a leporine model of gastroschisis.
    Feng C; Graham CD; Shieh HF; Brazzo JA; Connors JP; Rohrer L; Papadakis A; Zurakowski D; Fauza DO
    J Pediatr Surg; 2017 Jan; 52(1):30-34. PubMed ID: 27836365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy in a healthy model.
    Tracy SA; Chalphin AV; Lazow SP; Kycia I; Finkelstein A; Chan C; Zurakowski D; Fauza DO
    J Pediatr Surg; 2020 Jun; 55(6):1113-1116. PubMed ID: 32164983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital diaphragmatic hernia as a potential target for transamniotic stem cell therapy.
    Chalphin AV; Tracy SA; Lazow SP; Kycia I; Zurakowski D; Fauza DO
    J Pediatr Surg; 2020 Feb; 55(2):249-252. PubMed ID: 31753611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor mesenchymal stem cell kinetics after transamniotic stem cell therapy (TRASCET) in a rodent model of gastroschisis.
    Chalphin AV; Tracy SA; Kycia I; Chan C; Finkelstein A; Zurakowski D; Fauza DO
    J Pediatr Surg; 2020 Mar; 55(3):482-485. PubMed ID: 31813581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transamniotic stem cell therapy (TRASCET): An emerging minimally invasive strategy for intrauterine stem cell delivery.
    Moskowitzova K; Fauza DO
    Semin Perinatol; 2023 Apr; 47(3):151728. PubMed ID: 36990923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.